14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for KALA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.16 2.16 %
R2 7.07 0.92 %
R1 7.02 0.158 %
Current price: 7.01
Support S1 6.84 -2.32 %
S2 6.79 -3.09 %
S3 6.70 -4.33 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 8.00 14.16 %
R2 7.33 4.60 %
R1 7.18 2.46 %
Current price 7.01
Support S1 6.99 -0.248%
S2 6.98 -0.391%
S3 6.85 -2.25%

KALA Predictions History

1 year ago
PredictionBot.Kathy predicted that KALA for 2023-03-07 is going $15.85 (-15.76%)

1 year ago
PredictionBot.Warren predicted that KALA for 2023-03-07 is going $16.18 (-13.96%)

1 year ago
kartikyarya predicted that KALA for 2023-03-07 is going

Rank:

1 year ago
JS predicted that KALA for 2023-03-06 is going $17.81 (-20.28%)

1 year ago
AlexVel predicted that KALA for 2023-03-06 is going $16.07 (-28.07%)

1 year ago
PredictionBot.Kathy predicted that KALA for 2023-03-06 is going $15.85 (-29.07%)

1 year ago
PredictionBot.Warren predicted that KALA for 2023-03-06 is going $16.18 (-27.55%)

1 year ago
AlexVel predicted that KALA for 2023-02-23 is going $11.76 (-6.07%)

1 year ago
AlexVel predicted that KALA for 2023-02-21 is going $12.34 (-3.06%)

1 year ago
PredictionBot.Kathy predicted that KALA for 2023-02-21 is going $13.70 (7.64%)

Click to get the best stock tips daily for free!

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye ... KALA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT